Menu Search
Equities

American Well Corp

AMWL:NYQ

American Well Corp

Actions
Health CareHealth Care Providers
  • Price (USD)9.92
  • Today's Change0.09 / 0.92%
  • Shares traded48.79k
  • 1 Year change-61.55%
  • Beta1.0429
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year American Well Corp's revenues fell -6.55% from 277.19m to 259.05m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 270.43m to a larger loss of 675.16m.
Gross margin34.20%
Net profit margin-120.89%
Operating margin-128.56%
Return on assets-48.15%
Return on equity-62.06%
Return on investment-60.44%
More ▼

Cash flow in USDView more

In 2023, cash reserves at American Well Corp fell by 166.51m. Cash Flow from Financing totalled 2.15m or 0.83% of revenues. In addition the company used 148.34m for operations while cash used for investing totalled 19.17m.
Cash flow per share-18.92
Price/Cash flow per share--
Book value per share24.33
Tangible book value per share16.89
More ▼

Balance sheet in USDView more

American Well Corp appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio3.21
Quick ratio3.16
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.